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Abstract
Background: Chronic hepatitis C (CHC) is a medical condition that has broad implications for a person’s physical and 
psychological health. 
Objective: The aim of  this study was to detect changes in liver enzymes and psychological well-being in response to aerobic 
exercise training in patients with CHC. 
Material and Methods: Fifty CHC patients were included in two equal groups. The first group (A) received aerobic exercise 
training in addition to their regular medical treatment. The second group (B) received no training and only has their regular 
medical treatment. The program consisted of  three sessions per week for three months. 
Results: There was a significant decrease in mean values of  Alkaline Phosphatase (ALP), Alanine Aminotransferase  (ALT), 
Aspartate Aminotransferase (AST), Gamma – Glutamyltransferase (GGT) , Beck Depression Inventory (BDI )  & Profile 
of  Mood States(POMS) and  increase in Rosenberg Self-Esteem Scale (RSES) in group (A) after treatments, but the changes 
in group (B) were not significant. Also, there were significant differences between mean levels of  the investigated parameters 
in group (A) and group (B) at the end of  the study.
Conclusion: Aerobic exercise training improves hepatic enzymes and psychological well-being in patients with chronic 
hepatitis C. 
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Introduction
Chronic hepatitis C (CHC) is a major health problem 
with almost 160 million people infected worldwide [1]. 
Also, depression and fatigue are common in CHC [2]. 
The available treatment for HCV which consists of  a 
combination of  pegylated interferon (IFN) and ribavirin 
[3] is associated with numerous psychiatric side effects. 
Irritability, depression, and anxiety have been found to 
increase over the course of  treatment [4, 5]. Physical 
side effects of  IFN include fatigue, flu-like symptoms, 
pain, headache, nausea, and diarrhoea [6].  
These medication side effects can affect quality of  life, 
work functioning, energy level, emotional involvement, 
and physical mobility. So, treatment for HCV is lengthy, 
rigorous, and associated with side effects that are dif-
ficult to manage [7].  
Patients with HCV face numerous emotional and psy-
chosocial stressors that have a significant effect on well-
being. These stressors include adjusting to and manag-
ing this chronic disease and making lifestyle changes [8]. 
Consequently, mental health clinicians who work with 
HCV patients may find themselves unable to anticipate 
and unprepared to manage the diverse array of  psycho-
logical issues that they will encounter [9]. 
Physical activity is also associated with a reduced risk of  
developing depression and can lessen adverse reactions 
to stress and anxiety. Engaging in physical activities 
with others additionally offers opportunities for sociali-
zation and the development of  friendship networks, so 
reducing social isolation. Indeed, those who participate 
in regular physical activity frequently report ‘feeling bet-
ter’, a ‘sense of  achievement’ and ‘enjoyment’ [10]. 
Exercise is important for maintaining and improving 
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health in a variety of  chronic conditions [11]. Current 
research indicates that regular activity can be safely in-
corporated into the routine of  most people with chronic 
HCV and other chronic illnesses, and may positively af-
fect symptoms and health-related quality of  life. Light, 
regular physical activity may also have a beneficial im-
pact on insomnia, depression, pain, fatigue, and other 
side effects of  IFN treatment [12]. 
The aim of  this study was to detect changes in liver 
enzymes and psychological well-being in response to 
aerobic exercise training in patients with hepatitis C. 
Patients and methods
Subjects
We studied fifty chronic hepatitis C male patients. Their 
age ranged from 30 to 50 years with elevated liver en-
zymes; and body mass index ranged from 25-30km/
m2. Each subject received a detailed explanation of  the 
study and a consent form was assigned prior to partici-
pation. Diagnosis was made after thorough medical his-
tory taking, clinical examination, complete laboratory 
investigations including serological testing and abdomi-
nal ultrasonography. Exclusion criteria included: smok-
ing; hypertension, personal history of  cardiovascular 
diseases, thyroid disease, patient under anti-viral thera-
py and orthopedic problems inhibiting treadmill train-
ing. Subjects were assigned into two groups: The first 
group (A) received aerobic exercise training in addition 
the regular medical treatment. The second group (B) 
received the regular medical treatment. The program 
consisted of  three sessions per week for three months. 
All participants were free to withdraw from the study 
at any time. If  any adverse effects had occurred, the 
experiment would have been stopped, with this being 
announced to the Human Subjects Review Board. 
Chemical analysis
Blood samples were collected from the antecubital vein 
at the beginning and end of  the treatment program. 
Subjects had blood drawn at the same time in the morn-
ing on each occasion (between 8 and 10 am). Few ml of  
blood was drawn into a tube containing few milliliters 
of  sodium citrate; plasma was separated from the blood 
by centrifugation (120 × g for 15 min) at room temper-
ature. Liver enzymes (aspartate aminotransferase, AST; 
alanine aminotransferase, ALT; alkaline phosphatase, 
ALP and Gamma – Glutamyltransferase, GGT were 
measured by the colorimetric enzymatic method using 
an automatic spectrophotometer and respective kits for 
analysis (Bioclin, Quibasa, Belo Horizonte, MG, Brazil). 
All samples were assayed in duplicate, and the mean of  
the paired results was determined.
Psychological well-being
Data was collected at baseline and at the end of  treat-
ment. Participants were required to attend two labora-
tory sessions in order to complete all psychological as-
sessments, in each evaluation period. Self-esteem was 
assessed with the Rosenberg Self-Esteem Scale (RSES), 
composed by 10 items answered on a 4-point Likert 
Table (1): Mean value and significance of  ALP, ALT, AST, GGT, RSES, BDI and POMS in group (A) before 
and after treatment.
                                                  Mean +SD             T-value Significance
                                              Before After 
 
ALP (U/L)                 74.98 ± 7.61 57.43± 6.82 10.15             P < 0.05
ALT (U/L)                 46.77 ± 4.82 34.65± 4.13 9.52             P < 0.05
AST (U/L)                 44.63 ± 5.21 35.37± 4.81 9.86             P < 0.05
GGT(U/L)                 29.21 ± 4.52 22.35 ± 3.65 7.94             P < 0.05
Self-esteem (RSES)     23.75 ± 3.94 26.15 ± 3.22 6.43             P < 0.05
Depression (BDI)     7.52 ± 3.12             5.21 ± 3.05 4.98             P < 0.05
Total mood disturbance 
(POMS)                 23.74 ± 5.26 18.95 ± 4.61 6.33             P < 0.05
ALP: Alkaline Phosphatase                                      ALT: Alanine Aminotransferase                       
AST: Aspartate Aminotransferase                            GGT: Gamma – Glutamyltransferase
RSES: Rosenberg Self-Esteem Scale                         BDI: Beck Depression Inventory                   
POMS: Profile of  Mood States.
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scale. Higher scores of  the RSES represent greater self-
esteem (α = .84). Mood disturbance was assessed with 
the Profile of  Mood States (POMS), which measures the 
transient emotional state through 65 items on a 5-point 
Likert scale. The questionnaire assesses 6 dimensions 
of  mood that can be used to calculate a Total Mood 
Disturbance score (sum of  the negative emotions sub-
tracted by the positive Vigor dimension, α = .92), which 
was used in the present study (higher scores represent 
greater total mood disturbance). Questions pertain to 
emotional states of  the previous month. Depression was 
evaluated with the Beck Depression Inventory (BDI), a 
21-item inventory measuring several symptoms of  de-
pression. It uses a 4-point ordered scale and results in 
a total score (α = .80), where higher scores represent 
greater level of  depressive symptoms [13].  
     
Aerobic exercise training program
The aerobic treadmill-based training program (Enraf  
Nonium, Model display panel Standard, NR 1475.801, 
Holland) was set to 60% of  the maximum heart rate 
(HRmax) achieved according to a modified Bruce pro-
tocol. This rate was defined as the training heart rate 
(THR). After an initial, 5-minute warm-up phase per-
formed on the treadmill at a low load, each endur-
ance training session lasted 30 minutes and ended with 
5-minute recovery and relaxation phase. All patients 
performed three weekly sessions (that is a total of  36 
sessions per patient over a 3-month period. 
Statistical analysis 
The mean values of  ALP, ALT, AST, GGT, RSES, BDI 
and POMS obtained before and after three months in 
both groups were compared using paired "t" test. Inde-
pendent "t" test was used for the comparison between 
the two groups (P<0.05).
Results
There was a significant decrease in mean values of  Al-
kaline Phosphatase (ALP), Alanine Aminotransferase 
(ALT), Aspartate Aminotransferase (AST), Gamma – 
Glutamyltransferase (GGT) , Beck Depression Inven-
tory (BDI )  & Profile of  Mood States(POMS) and  in-
crease in Rosenberg Self-Esteem Scale (RSES) in group 
(A) after treatments (table 1)
But the changes in group (B) were not significant (table 
2). 
Table (2): Mean value and significance of  ALP, ALT, AST, GGT, RSES, BDI and POMS in group (B) before and 
after treatment.
                                                       Mean +SD T-value         T-value     Significance
                                                     Before After 
 
ALP (U/L)                              73.46 ± 8.21 73.91 ± 8.23 0.83    P > 0.05
ALT (U/L)                              47.02 ± 4.65 47.86 ± 4.32 0.91    P > 0.05
AST (U/L)                              46.74 ± 4.71 46.93 ± 4.14 0.65    P > 0.05
GGT(U/L)                              29.42 ± 4.65 29.75 ± 4.33 0.58    P > 0.05
Self-esteem (RSES)                  23.52 ± 3.86 23.25± 3.57 0.47    P > 0.05
Depression (BDI)                  7.66 ± 3.41             7.87 ± 3.11 0.51    P > 0.05
Total mood disturbance 
(POMS)                              23.88 ± 5.47 24.92 ± 5.25 1.26    P > 0.05
ALP: Alkaline Phosphatase                                       ALT: Alanine Aminotransferase                       
AST: Aspartate Aminotransferase                             GGT: Gamma – Glutamyltransferase
RSES: Rosenberg Self-Esteem Scale                         BDI: Beck Depression Inventory                   
POMS: Profile of  Mood States.
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Also, there were significant differences between mean levels of  the investigated parameters in group (A) and group 
(B) at the end of  the study (table 3).
Table (3): Mean value and significance of  Table (1): Mean value and significance of  ALP, ALT, AST, GGT, RSES, 
BDI and POMS in group (A) and group (B) after treatment.
 
                                           Mean +SD             T-value             Significance
                     Group (A) Group (B)  
ALP (U/L)             57.43± 6.82 73.91 ± 8.23 7.63              P < 0.05
ALT (U/L)             34.65± 4.13 47.86 ± 4.32 6.72              P < 0.05
AST (U/L)             35.37± 4.81 46.93 ± 4.14 6.41              P < 0.05
GGT(U/L)             22.35 ± 3.65 29.75 ± 4.33 5.34              P < 0.05
Self-esteem (RSES) 26.15 ± 3.22 23.25± 3.57 4.23              P < 0.05
Depression (BDI) 5.21 ± 3.05 7.87 ± 3.11 3.62              P < 0.05
Total mood disturbance 
(POMS)             18.95 ± 4.61 24.92 ± 5.25 4.41              P < 0.05
ALP: Alkaline Phosphatase                                      ALT: Alanine Aminotransferase                       
AST: Aspartate Aminotransferase                            GGT: Gamma – Glutamyltransferase
RSES: Rosenberg Self-Esteem Scale                        BDI: Beck Depression Inventory                  
POMS: Profile of  Mood States.
Discussion
As exercise is a low-cost, reliable and sustainable thera-
py for many chronic diseases [14-17]. Increased exercise 
duration and intensity has been evaluated as an impor-
tant therapeutic intervention in treating patients with 
non-alcoholic fatty liver disease (NAFLD) and chronic 
liver disease [18].  So, the aim of  this study was to detect 
changes in liver enzymes and psychological well-being 
in response to aerobic exercise training in patients with 
chronic hepatitis C. The results of  the present study 
indicated that there was a significant improvement in 
liver enzymes and psychological well-being response to 
aerobic exercise training in patients with CHC.
The benefit of  exercise on the liver is supported by 
other multicentre studies or meta-analyses showing its 
favourable effect on ALT levels and steatosis [19-21]. 
A ret-rospective analysis by Kistler et al., which evalu-
ated the association between physical activity intensity 
and histological severity of  NAFLD, demonstrated a 
signifi¬cant decrease in histological severity with vigor-
ous exercise (P = 0.04) but no differ¬ence in ALT levels 
[19].Two systematic reviews by Musso et al. and Thoma 
et al., albeit both with small sample sizes, showed that 
exercise reduces levels of  liver enzymes and steatosis 
regardless of  weight loss [20, 21].  
Nasif   et al., conducted a study  on 40 patients with 
chronic HCV who were randomly assigned into two 
groups, experimental group (Group I), who received 
aerobic exercise of  moderate intensity for two months, 
two sessions a week, 30 minutes for each session, and a 
control group (Group II), who did not receive exercise. 
Their mean age was (40±5 years) and aerobic exercise 
training of  moderate intensity led to decrease serum 
levels of  liver enzymes (AST and ALT) which means 
protection of  hepatic cells and restoration of  its func-
tion [22]. Also, McKenna etal.  conducted a single-blind 
randomized controlled trial on twenty-two patients with 
hepatitis C in Ireland. Participants were randomly as-
signed to exercise (n = 10) and control (n = 12) groups. 
The exercise group attended 12 exercise sessions for 6 
weeks. Results showed significant improvements in the 
measures of  grip strength, aerobic capacity and depres-
sion with the exercise group showing greater positive 
change. The exercise group also had superior gains in 
the 36-Item Short-Form Health Survey vitality and so-
cial function scores [23].   
Hickman etal., concluded that thirty one patients with 
chronic liver disease who completed a 15 month diet 
and exercise intervention resulted in a sustained im-
provement in liver enzymes, serum insulin levels, and 
quality of  life. Treatment of  overweight patients should 
African Health sciences Vol 14 No. 2 June 2014                   417
form an important component of  the management of  
those with chronic liver disease [24].   However, a meta-
analysis by Keating et al. included combined data from 
12 (n = 439) trials of  exercise intervention in patients 
with NAFLD (11 of  which were randomized control-
led trials), with levels of  liver fat and liver enzymes as 
the main outcome measures. The analysis showed that 
aerobic exercise and/or progressive resistance training 
significantly reduced liver fat independent of  diet and 
weight loss which provided positive evidence of  the in-
dependent effect of  exercise, and thus supports its role 
as a therapy for NAFLD [15].  Another study applied 
on twelve volunteer patients with hepatitis C, who were 
sedentary and had been treated by combination therapy 
for the past few weeks. The patients came to a sports 
facility daily for 5 days for the exercise program. Quali-
ty-of-life (SF36) was assessed at enrolment in the study 
and one month after the training sessions. The score 
of  the general perception item of  the SF36 question-
naire increased from 63 on day 0 to 71 at one month (p 
= 0.07). Participating in sports activities could improve 
self-confidence and lead to far-reaching changes in the 
way patients perceive their disease and the constraints 
of  treatment [25].  
The direct mechanism by which exercise exerts its ef-
fect on the liver remains to be clarified. Exercise im-
proves whole body lipid oxidation and steatosis by 
augmenting fatty acid and hepatic lipid metabolism [19, 
20].The molecular mechanisms by which exercise alters 
regulation of  lipid homeostasis are under investiga-
tion. The activation of  hepatic and muscle adeno¬sine 
monophosphate-activated protein kinase (AMPK) in-
creases non-esterified fatty acid oxidation and decreases 
hepatic glucose production [16, 19]. Moreover AMPK 
is thought to signal expression of  peroxi¬some prolif-
erator-activated receptor-delta to suppress stellate cell 
proliferation [19].  
Conclusion
Aerobic exercise training improves liver enzymes and 
psychological well-being in patients with chronic hepa-
titis C. 
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